Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Paracrine Crosstalk between Intestinal L- and D-cells Controls Secretion of Glucagon-Like Peptide-1 in mice

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Sara L Jepsen
  • Kaare V Grunddal
  • Nicolai J Wewer Albrechtsen
  • Maja S Engelstoft
  • Maria B N Gabe
  • Elisa P Jensen
  • Cathrine Ørskov
  • Steen S Poulsen
  • Mette M Rosenkilde
  • Jens Pedersen
  • Fiona M Gribble
  • Frank Reimann
  • Carolyn F Deacon
  • Thue W Schwartz
  • Andreas D Christ
  • Rainer E Martin
  • Jens J Holst
View graph of relations

DPP-4 inhibitors, used for treatment of type 2 diabetes, act by increasing the concentrations of intact glucagon-like peptide-1 (GLP-1), but at the same time, they inhibit secretion of GLP-1, perhaps by a negative feedback mechanism. We hypothesized that GLP-1 secretion is feedback regulated by somatostatin (SS) from neighboring D-cells, and blocking this feedback circuit results in increased GLP-1 secretion. We used a wide range of experimental techniques, including gene expression analysis, immunohistochemical approaches, and the perfused mouse intestine to characterize the paracrine circuit controlling GLP-1 and SS. We show that 1) antagonizing the SS receptor (SSTr) 2 and SSTr5 led to increased GLP-1 and SS secretion in the mouse, 2) SS exhibits strong tonic inhibition of GLP-1 secretion preferentially through SSTr5, and 3) the secretion of S was GLP-1 receptor dependent. We conclude that SS is a tonic inhibitor of GLP-1 secretion, and interventions in the somatostain-GLP-1 paracrine loop lead to increased GLP-1 secretion.

Original languageEnglish
JournalAmerican Journal of Physiology: Endocrinology and Metabolism
Issue number6
Pages (from-to)E1081-E1093
Publication statusPublished - 2019

    Research areas

  • GLP-1, paracrine loop, somatostatin, somatostatin receptors, SSTr antagonist

ID: 57969503